NCT01043640 Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders Status COMPLETED Phase PHASE2
NCT00937794 Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase® Status COMPLETED Phase N/A
NCT00920647 A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase® Status COMPLETED Phase PHASE1/PHASE2
NCT00882921 An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients Status COMPLETED Phase N/A
NCT00630747 Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase Status COMPLETED Phase PHASE2/PHASE3
NCT00607386 Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy Status COMPLETED Phase PHASE4